Expertise in
29
conditions

Dr. Mark L. Moster

Ophthalmology | Neurology
Neuro-Ophthalmologic Associates PC
840 Walnut St Ste 930, 
Philadelphia, PA 
Expertise in
29
conditions
Neuro-Ophthalmologic Associates PC
840 Walnut St Ste 930, 
Philadelphia, PA 

Overview

Mark Moster is an Ophthalmologist and a Neurologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Moster is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Optic Nerve Atrophy, Leber Hereditary Optic Neuropathy (LHON), Papilledema, Temporal Arteritis, and Vitrectomy.

He is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 7 clinical trials.

Specialties

Ophthalmology
Neurology

Licenses

Psychiatry & Neurology in PA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Neuro-Ophthalmologic Associates PC
840 Walnut St Ste 930, Philadelphia, PA 19107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Enrollment Status: Completed
Publish Date: April 16, 2026
Intervention Type: Genetic, Drug
Study Phase: Phase 3
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Enrollment Status: Completed
Publish Date: March 02, 2026
Intervention Type: Biological, Device
Study Phase: Phase 3
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
Enrollment Status: Completed
Publish Date: March 02, 2026
Intervention Type: Biological, Device
Study Phase: Phase 3
Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)
Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)
Enrollment Status: Completed
Publish Date: March 02, 2026
Intervention Type: Genetic, Other
Study Phase: Phase 3
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Enrollment Status: Completed
Publish Date: March 02, 2026
Intervention Type: Other
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
Enrollment Status: Terminated
Publish Date: October 12, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis
Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis
Enrollment Status: Completed
Publish Date: August 22, 2017
Intervention Type: Drug
Study Phase: Early Phase 1
View 6 Less Clinical Trials

43 Total Publications

Venous manometry triage in refractory idiopathic intracranial hypertension: imaging and criteria validity.
Venous manometry triage in refractory idiopathic intracranial hypertension: imaging and criteria validity.
Journal: Journal of neurointerventional surgery
Published: October 03, 2025
Similar Doctors
Expertise in
49
conditions
Dr. Carol L. Shields
Ophthalmology | Oncology
Expertise in
49
conditions
Dr. Carol L. Shields
Ophthalmology | Oncology
Referral may be required
Before you request

Ophthalmology - Wills Eye Hospital

840 Walnut Street, Floor 10, 
Philadelphia, PA 
 (0.3 miles away)
215-928-3105
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Carol Shields is an Ophthalmologist and an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Shields is highly rated in 49 conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is board certified in Ophthalmology. Dr. Shields is currently accepting new patients.

Expertise in
16
conditions
Dr. Irene V. Gottlob
Ophthalmology | Neurology
Expertise in
16
conditions
Dr. Irene V. Gottlob
Ophthalmology | Neurology
Referral may be required

Cooper Specialty Care At Cherry Hill Campus

2339 Route 70 West, 
Cherry Hill, NJ 
 (7.1 miles away)
856-546-8525
Experience:
44+ years
Languages Spoken:
English, French, German
See accepted insurances
Accepting New Patients

Irene Gottlob is an Ophthalmologist and a Neurologist practicing medicine in Cherry Hill, New Jersey. She has been practicing medicine for over 44 years. Dr. Gottlob is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses X-Linked Infantile Nystagmus, Albinism, Brown Syndrome, and Color Blindness. Dr. Gottlob is board certified in American Board Of Ophthalmology,Ophthalmology. Dr. Gottlob is currently accepting new patients.

Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required
Before you request

Vickie & Jack Farber Institute For Neuroscience - Honickman Center

1101 Chestnut Street, Floor 10, 
Philadelphia, PA 
 (0.1 miles away)
215-955-1222
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Sperling is a Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Sperling is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Absence Seizure, and Deep Brain Stimulation. Dr. Sperling is board certified in Neurology. Dr. Sperling is currently accepting new patients.

Frequently Asked Questions about Dr. Mark L. Moster

How do I make an appointment with Dr. Mark L. Moster?

You can book an appointment with Dr. Mark L. Moster by calling their office at 215-456-7890. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark L. Moster a top-rated expert for Optic Nerve Atrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark L. Moster is classified as an Elite expert for Optic Nerve Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark L. Moster specialize in?

While Dr. Mark L. Moster is a Ophthalmology, they have specific expertise in Optic Nerve Atrophy, Leber Hereditary Optic Neuropathy (LHON), and Papilledema. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Mark L. Moster participate in research or clinical trials?

Yes. Dr. Mark L. Moster has published 43 articles and abstracts on conditions like Optic Nerve Atrophy. You can view a list of Dr. Mark L. Moster's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark L. Moster accept my insurance?

Dr. Mark L. Moster accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 215-456-7890 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moster's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 19 Advanced Conditions
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile